Stockscreener 앱 받기
0.88
1.38%
0.012
시간 외 거래:
.90
0.02
+2.27%
전일 마감가:
$0.868
열려 있는:
$0.86
하루 거래량:
74,067
Relative Volume:
0.42
시가총액:
$53.65M
수익:
-
순이익/손실:
$-112.67M
주가수익비율:
-0.4513
EPS:
-1.95
순현금흐름:
$-79.26M
1주 성능:
+13.24%
1개월 성능:
-6.38%
6개월 성능:
-8.81%
1년 성능:
-19.27%
1일 변동 폭
$0.85
$0.90
1주일 범위
$0.77
$0.92
52주 변동 폭
$0.69
$1.60
크로노스 Stock (KRON) Company Profile
명칭
Kronos Bio Inc
전화
(650) 781-5200
주소
1300 S. EL CAMINO REAL, SAN MATEO
KRON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRON
Kronos Bio Inc
|
0.88 | 53.65M | 0 | -112.67M | -79.26M | -1.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.89 | 124.91B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.28 | 60.05B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
587.59 | 35.88B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.50 | 29.83B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
228.14 | 24.58B | 3.81B | -644.79M | -669.77M | -6.24 |
크로노스 Stock (KRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-14 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2022-09-14 | 개시 | Berenberg | Buy |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-06-24 | 개시 | H.C. Wainwright | Buy |
| 2020-11-03 | 개시 | Cowen | Outperform |
| 2020-11-03 | 개시 | Goldman | Buy |
| 2020-11-03 | 개시 | Jefferies | Buy |
| 2020-11-03 | 개시 | Piper Sandler | Overweight |
모두보기
크로노스 주식(KRON)의 최신 뉴스
Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com South Africa
Kronos Bio Announces Lease Termination Agreement - TipRanks
Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times
Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
Kronos Bio Reports 2024 Financial Results - TipRanks
Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023) - Yahoo Finance
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Kronos Bio earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada
Kronos Bio Inc (KRON) Q4 2024 Earnings: EPS Misses at -$0.43, Re - GuruFocus.com
Kronos Bio, Inc. SEC 10-K Report - TradingView
China Revives Its Carbon Credit Market: Price Swings & Future Outlook - The Globe and Mail
Navigating the U.S. Planting Season with Enhanced Risk Management - The Globe and Mail
Shootin' the Bull about cattle feeders - The Globe and Mail
KRONOS BIO Earnings Preview: Recent $KRON Insider Trading, Hedge Fund Activity, and More - Nasdaq
Kronos Bio (KRON) to Release Quarterly Earnings on Thursday - Defense World
Kronos Bio Insider Ups Holding By 36% During Year - Yahoo Finance
Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat
Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN
Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat
We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat
Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia
Kronos Bio ends partnership with Genentech - Investing.com India
Kronos Bio Ends Collaboration with Genentech and Roche - TipRanks
Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat
크로노스 (KRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
크로노스 주식 (KRON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 28 '24 |
Buy |
1.25 |
204,670 |
254,957 |
10,802,138 |
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 10 '24 |
Buy |
0.88 |
1,378,901 |
1,208,469 |
5,749,395 |
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 12 '24 |
Buy |
1.24 |
881,913 |
1,096,041 |
7,375,616 |
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 11 '24 |
Buy |
1.09 |
744,308 |
814,571 |
6,493,703 |
0.21%
1.22%
자본화:
|
볼륨(24시간):